Your shopping cart is currently empty

Hsp90-IN-42 (Compound 13l) is a potent inhibitor of heat shock protein 90 (Hsp90) with an IC50 of 15.65 nM. It destabilizes the epidermal growth factor receptor (EGFR), inhibits the activation of the EGFR-Akt signaling pathway, induces G0/G1 phase arrest, and slightly triggers apoptosis in colorectal cancer cells, such as HT-29 cells. Additionally, Hsp90-IN-42 suppresses cell proliferation and migration by downregulating CDK12, CDK13, and Bcl-2 protein expression while upregulating Bax protein expression. This compound shows potential for research in colorectal cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | Hsp90-IN-42 (Compound 13l) is a potent inhibitor of heat shock protein 90 (Hsp90) with an IC50 of 15.65 nM. It destabilizes the epidermal growth factor receptor (EGFR), inhibits the activation of the EGFR-Akt signaling pathway, induces G0/G1 phase arrest, and slightly triggers apoptosis in colorectal cancer cells, such as HT-29 cells. Additionally, Hsp90-IN-42 suppresses cell proliferation and migration by downregulating CDK12, CDK13, and Bcl-2 protein expression while upregulating Bax protein expression. This compound shows potential for research in colorectal cancer. |
| Targets&IC50 | HSP90:15.65 nM |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.